Involvement of liver kinase B1 in the ameliorative action of epigallocatechin-3-gallate against MAFLD progression in mice

Involvement of liver kinase B1 in the ameliorative action of epigallocatechin-3-gallate against MAFLD progression in mice

Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by intrahepatic fat accumulation in individuals without a history of excessive alcohol consumption. This study investigated the effects of epigallocatechin-3-gallate (EGCG) on reducing MAFLD severity. Twenty-four ddY mice...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahardian Rahmadi, Chia-Wei Phan, Santhra Segaran Balan, Athallah Syauqi Zumarthana, Ellyna Majesty Ayundari, Ismailia Wienda Yasmin Pratama Putri, Salsabila, Ahmad Dzulfikri Nurhan
Format: Article
Language:English
Published: Pensoft Publishers 2025-08-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/159024/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items